%0 Journal Article %J Reumatologia/Rheumatology %@ 0034-6233 %V 52 %N 2 %D 2014 %F Dąbrowski2014 %T Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis – impact of treatment %X Chronic inflammation – the crucial pathogenic mechanism of rheumatoid arthritis and ankylosing spondylitis – is the main cause of accelerated atherosclerosis, insulin resistance and well-known consequences related to it. The conservative treatment of rheumatoid arthritis and ankylosing spondylitis may provide a significant influence on glucose metabolism. The paper is a literature overview concerning insulin resistance and impaired glucose metabolism during treatment with disease-modifying drugs including biologic DMARDs (disease-modifying antirheumatic drugs), corticosteroids and commonly used non-steroidal anti-inflammatory drugs (NSAID). It has been found that the risk of carbohydrate disorders among those patients is much lower after therapy with hydroxychloroquine, methotrexate and TNF blockers – particularly with infliximab. The NSAID may play an important protective role in reducing risk of diabetes. The recent data show, contrary to general opinion, the advantageous outcome for glucose metabolism after treatment with corticosteroids, especially in the early active stage of rheumatoid arthritis. %A Dąbrowski, Piotr %A Majdan, Maria %P 129-135 %9 journal article %R 10.5114/reum.2014.42798 %U http://dx.doi.org/10.5114/reum.2014.42798